Home/Pipeline/Antibiotic Development Program

Antibiotic Development Program

Infectious Disease

Pre-clinicalActive

Key Facts

Indication

Infectious Disease

Phase

Pre-clinical

Status

Active

Company

AF ChemPharm

About AF ChemPharm

AF ChemPharm is a private, revenue-generating chemistry services CRO founded in 2005 and based in Sheffield, UK. The company leverages a team of PhD chemists and a distinguished scientific advisory board to offer custom synthesis, contract research, and consultancy, accelerating drug discovery projects for global clients. Its core value proposition is acting as an extension of a client's research team, de-risking and accelerating R&D through high-quality, rapid-turnaround chemistry services. While primarily a service provider, it has also engaged in internal research programs, such as developing a new generation of antibiotics.

View full company profile

Other Infectious Disease Drugs

Drug	Company	Phase	Status
Vaccine Platform	Biolingus	Research	Active
Pipeline Antibiotics	BioQ Pharma	Unknown	Active
Antivirals Platform	Qubit Pharmaceuticals	Discovery	Active
Prophylactic Vaccine Development	ImmuneSpec	Service	Active
Optimized VHH vs. SARS-CoV-2	Ordaos Bio	Pre-clinical	Active
AmorphOX Vaccine	Orexo	Preclinical	Active (with Abera)
Undisclosed Vaccine Program(s)	Brazos Biomedical	Pre-clinical	Active
Undisclosed Asset 1	Uvax Bio	Research	Active
Undisclosed Asset 2	Uvax Bio	Research	Active
Undisclosed Asset 3	Uvax Bio	Research	Active
Vaccine Immune Response (SARS-CoV-2)	CellChorus	Preclinical	Active
POCKIT™ Central COVID-19 Assay	GeneReach Biotechnology	commercial	Active